Skip to content
    Canaan Partners logo

    Canaan Partners

    Stamford, Connecticut, United StatesFounded 1987

    Canaan Partners is an early-stage venture capital firm founded in 1987 that invests in technology and healthcare companies. The firm closed its 13th flagship fund, Canaan XIII, at $650 million in April 2023, bringing total capital raised across its history to over $1 billion since early 2023.

    Average disclosed round size is $40.3M (across 487 rounds with reported amounts).

    Find people at Canaan Partners on Goldilocks AI

    Portfolio

    290

    Fund Size

    $650M

    Top Stage

    Series B

    Last 12 Mo

    7

    Team

    Antonio Lepore

    Antonio Lepore

    Brendan Dickinson

    Brendan Dickinson

    Brent Ahrens

    Brent Ahrens

    Colleen Cuffaro

    Colleen Cuffaro

    Dana Malman Warren

    Dana Malman Warren

    Deepak Kamra

    Deepak Kamra

    Derek Wu

    Derek Wu

    Evan Teiger

    Evan Teiger

    Felipe Ossio

    Felipe Ossio

    Howard Greenfield

    Howard Greenfield

    Hrach Simonian

    Hrach Simonian

    Janet Bell

    Janet Bell

    Portfolio Breakdown

    Stage Distribution

    Sector Distribution

    Investment Activity

    DealsAvg Round Size

    Portfolio

    532 investments
    CompanyRoundAmountDate
    AAgomabSeries A$100MSep 2026
    Solstice logoSolsticeSeries A$21MMay 2026
    Hermeus logoHermeusSeries C—Apr 2026
    VVimaSeries A$100MMar 2026
    RenoFi logoRenoFiSeries B$22MMar 2026
    Tomorrow.io logoTomorrow.ioGrowth—Feb 2026
    Rapidata logoRapidataSeed$8.5MJan 2026
    OpenArt logoOpenArtSeries A$5MJan 2026
    Mate Security logoMate SecuritySeries A$35MJan 2026
    Vedana Therapeutics logoVedana TherapeuticsSeries A$46MJan 2026
    VVima Therapeutics, Inc.Unknown$40MJan 2026
    RRevisionSeries D—Jan 2026
    Sumble logoSumbleSeries A$38.5MOct 2025
    DDoorstep AiSeed$8MSep 2025
    Field AI logoField AIGrowth—Aug 2025
    Abvance Therapeutics logoAbvance TherapeuticsSeed—Jun 2025
    Draig Therapeutics logoDraig TherapeuticsSeries A$140MJun 2025
    ThirtyFiveBio logoThirtyFiveBioBridge—Apr 2025
    HeyMilo AI logoHeyMilo AISeed$2.2MMar 2025
    Valid logoValidSeed$5.5MFeb 2025
    Clutch logoClutchSeries B$65MJan 2025
    Draig Therapeutics logoDraig TherapeuticsSeries A$140MJan 2025
    WiseLayer logoWiseLayerSeed$7.2MJan 2025
    AttoTude logoAttoTudeSeries B$50MJan 2025
    HeyMilo AI logoHeyMilo AISeed$2.2MJan 2025
    Page 1 of 22

    Top Co-Investors

    Last updated: 27 September 2026